FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Matthew Gipson

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Liudmila Kulik; Kevin J Marchbank; Taras Lyubchenko; Kristine A Kuhn; Ganna A Liubchenko; Catherine Haluszczak; Matthew G Gipson; Matthew G Gibson; Susan A Boackle; V Michael Holers
Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
Kevin J Marchbank; Liudmila Kulik; Matthew G Gipson; B Paul Morgan; V Michael Holers
Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia.
Sherry D Fleming; Terez Shea-Donohue; Guthridge Joel; Liudmila Kulik; Thomas J Waldschmidt; Matthew G Gipson; George C Tsokos; V Michael Holers
Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Matthew Gipson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Liudmila Kulik; Kevin J Marchbank; Taras Lyubchenko; Kristine A Kuhn; Ganna A Liubchenko; Catherine Haluszczak; Matthew G Gipson; Matthew G Gibson; Susan A Boackle; V Michael Holers
Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2/CD21 during B cell development.
European journal of immunology 2007;37(3):623-33.
2002: Kevin J Marchbank; Liudmila Kulik; Matthew G Gipson; B Paul Morgan; V Michael Holers
Expression of human complement receptor type 2 (CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(7):3526-35.
2002: Sherry D Fleming; Terez Shea-Donohue; Guthridge Joel; Liudmila Kulik; Thomas J Waldschmidt; Matthew G Gipson; George C Tsokos; V Michael Holers
Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(4):2126-33.
2001: Guthridge Joel; K Young; Matthew G Gipson; Maria-Rosa Sarrias; Gerda Szakonyi; Xiaojiang S Chen; A Malaspina; Eileen T Donoghue; Judith A James; John D Lambris; Susan Moir; Stephen J Perkins; V Michael Holers
Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2)/CD21: identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(10):5758-66.
2001: Guthridge Joel; Jonathan K Rakstang; Kendra A Young; J Hinshelwood; Mohammed Aslam; Alexis Robertson; Matthew G Gipson; Maria-Rosa Sarrias; WT Moore; M Meagher; David R Karp; John D Lambris; Stephen J Perkins; V Michael Holers
Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg.
Biochemistry 2001;40(20):5931-41.